Citius Oncology Inc (NASDAQ:CTOR) concluded the trading at $3.5 on Thursday, June 26 with a rise of 26.81% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $2.76 and 5Y monthly beta was reading -0.063 with its price kept floating in the range of $2.661 and $3.3188 on the day. Considering stock’s 52-week price range provides that CTOR hit a high price of $49.00 and saw its price falling to a low level of $0.55 during that period. Over a period of past 1-month, stock came adding 293.26% in its value.
With its current market valuation of $250.43 million, Citius Oncology Inc is set to declare its quarterly results on 2025-May-14. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 0 for current year with estimates of that growing to 0 in next year.
In contrast, when we review CTOR stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 75% Buy. Long term indicators are suggesting an average of 50% Buy for it.
Digging deeper we become aware of the PEG ratio of the CTOR stock which is currently positioned at 0. It further provides that stock’s current price level is 119.69% away from its 20-day simple moving average and is 209.60% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 91.89 while volatility remained at 48.17% over the past week which changes to 20.21% when measuring it over the past month. Beta is valued at 0.70.
Having a second look at Citius Oncology Inc (NASDAQ:CTOR) provides that stock’s average daily trading volume for 3 months was 2.03 million, while it jumped to 3668710 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 71.55 million.
The percentage of outstanding shares held by the insiders is 95.08% while it is 0.15% for the institutional holders. The figures also indicate that as of 2025-06-13, number of stock’s short shares was 0.11 million which implies a short ratio of 0.17. This shows up a 206.00 of Short Interest in company’s outstanding shares on the day. In June the standing of shares short improved as it was 47100.0 in the previous month. Subtraction of -69.11% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
